BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,414,313 | -22.6% | 37,475 | -6.6% | 0.00% | 0.0% |
| Q2 2023 | $1,827,076 | +12.6% | 40,102 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $1,623,330 | -17.0% | 40,023 | +4.4% | 0.00% | -33.3% |
| Q4 2022 | $1,954,934 | -8.0% | 38,354 | -2.8% | 0.00% | -25.0% |
| Q3 2022 | $2,126,000 | -17.6% | 39,469 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $2,581,000 | -30.6% | 40,177 | -16.2% | 0.00% | -33.3% |
| Q1 2022 | $3,720,000 | +12.6% | 47,970 | +24.5% | 0.01% | +20.0% |
| Q4 2021 | $3,305,000 | -8.0% | 38,519 | -13.8% | 0.01% | -28.6% |
| Q3 2021 | $3,592,000 | +38.8% | 44,667 | +38.9% | 0.01% | +40.0% |
| Q2 2021 | $2,588,000 | -4.1% | 32,160 | +0.5% | 0.01% | -16.7% |
| Q1 2021 | $2,699,000 | +5.5% | 31,996 | +0.3% | 0.01% | 0.0% |
| Q4 2020 | $2,559,000 | +2.8% | 31,894 | +3.1% | 0.01% | -14.3% |
| Q3 2020 | $2,489,000 | -9.1% | 30,940 | -2.7% | 0.01% | -12.5% |
| Q2 2020 | $2,737,000 | +5.1% | 31,794 | -0.9% | 0.01% | -20.0% |
| Q1 2020 | $2,604,000 | -5.6% | 32,075 | -2.8% | 0.01% | +11.1% |
| Q4 2019 | $2,758,000 | -12.4% | 32,986 | -8.3% | 0.01% | -25.0% |
| Q3 2019 | $3,147,000 | +7.3% | 35,976 | +0.5% | 0.01% | 0.0% |
| Q2 2019 | $2,932,000 | -17.9% | 35,799 | -18.5% | 0.01% | -25.0% |
| Q1 2019 | $3,572,000 | +25.4% | 43,919 | +1.5% | 0.02% | +14.3% |
| Q4 2018 | $2,849,000 | -9.4% | 43,287 | +5.0% | 0.01% | -12.5% |
| Q3 2018 | $3,146,000 | -3.7% | 41,227 | -6.8% | 0.02% | -11.1% |
| Q2 2018 | $3,266,000 | +14.1% | 44,236 | +0.5% | 0.02% | +5.9% |
| Q1 2018 | $2,863,000 | -12.8% | 44,008 | -13.3% | 0.02% | -19.0% |
| Q4 2017 | $3,283,000 | -7.0% | 50,784 | -9.7% | 0.02% | -16.0% |
| Q3 2017 | $3,529,000 | +0.7% | 56,238 | -2.9% | 0.02% | -10.7% |
| Q2 2017 | $3,504,000 | +20.7% | 57,891 | +3.4% | 0.03% | +7.7% |
| Q1 2017 | $2,904,000 | -0.2% | 56,004 | -13.8% | 0.03% | -18.8% |
| Q4 2016 | $2,911,000 | +403.6% | 64,947 | +434.9% | 0.03% | -15.8% |
| Q3 2016 | $578,000 | -83.6% | 12,142 | -84.4% | 0.04% | -24.0% |
| Q2 2016 | $3,514,000 | +23.4% | 77,742 | +13.4% | 0.05% | +8.7% |
| Q1 2016 | $2,848,000 | +53.0% | 68,581 | +40.5% | 0.05% | +24.3% |
| Q4 2015 | $1,862,000 | +16.2% | 48,809 | +0.1% | 0.04% | -2.6% |
| Q3 2015 | $1,602,000 | -46.3% | 48,750 | +14.3% | 0.04% | -50.6% |
| Q2 2015 | $2,983,000 | +11.8% | 42,637 | +9.5% | 0.08% | +2.7% |
| Q1 2015 | $2,668,000 | +19.0% | 38,937 | +27.3% | 0.08% | +8.7% |
| Q4 2014 | $2,242,000 | +10.0% | 30,586 | +7.7% | 0.07% | -2.8% |
| Q3 2014 | $2,039,000 | +28.0% | 28,407 | +28.9% | 0.07% | +14.5% |
| Q2 2014 | $1,593,000 | -16.3% | 22,038 | -14.8% | 0.06% | -22.5% |
| Q1 2014 | $1,903,000 | +16.5% | 25,865 | +10.1% | 0.08% | +8.1% |
| Q4 2013 | $1,633,000 | +18.7% | 23,486 | +12.1% | 0.07% | +2.8% |
| Q3 2013 | $1,376,000 | -11.2% | 20,947 | -6.4% | 0.07% | -22.6% |
| Q2 2013 | $1,550,000 | – | 22,376 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |